HLN 9.98 (-1.09%)
US4055521003Drug ManufacturersDrug Manufacturers - Specialty & Generic

Haleon (HLN) Competitor Comparison

We are evaluating the key criteria listed to compare Haleon (HLN) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 10 years - HLN ranking 0 / 54

These are the competitors of Haleon in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 10 years
1. Phibro Animal Health PAHC
286.2
2. Theratechnologies THTX
87.24
3. Avadel Pharmaceuticals AVDL
23.43
4. Green Thumb Industries R9U2.F
12.22
5. Eagle Pharmaceuticals EGRX
9.12
6. Regencell Bioscience Holdings RGC
8.49
7. Emergent BioSolutions EBS
7.73
8. Alimera Sciences ALIM
7.61
9. Vifor Pharma G2AB.F
7.23
10. Alvotech ALVO
7.1
11. Linc LNC
7.07
12. ProPhase Labs PRPH
6.89
13. Kamada KMDA
6.67
14. PetIQ PETQ
5.43
15. Kolinpharma KIP.MI
4.84
16. Ayr Wellness 3KJB.F
4.39
17. Ironwood Pharmaceuticals IRWD
4.37
18. Societal CDMO SCTL
3.72
19. Evolus EOLS
3.64
20. Curaleaf Holdings CURLF
3.62
21. Cumberland Pharmaceuticals CPIX
3.55
22. Organogenesis Holdings ORGO
3.32
23. Elanco Animal Health ELAN
3.2
24. Amneal Pharmaceuticals AMRX
3.09
25. Journey Medical DERM
2.98
26. Taro Pharmaceutical Industries TARO
2.87
27. Procaps Group PROC
2.8
28. Cronos Group CRON
2.74
29. Embecta EMBC
2.52
30. Tilray Brands TLRY
2.34
31. ANI Pharmaceuticals ANIP
2.34
32. Teva Pharmaceutical Industries TEVA
2.31
33. Neoleukin Therapeutics NLTX
2.29
34. Catalent CTLT
2.18
35. Pacira BioSciences PCRX
2.1
36. Perrigo PRGO
2.08
37. Alpha Teknova TKNO
1.9
38. Jupiter Wellness JUPW
1.84
39. Biofrontera BFRI
1.78
40. Flora Growth FLGC
1.77
41. Ascend Wellness Holdings AAWH
1.76
42. OptiNose OPTN
1.72
43. Bausch Health Companies BHC
1.64
44. Zynerba Pharmaceuticals ZYNE
1.63
45. Clever Leaves Holdings CLVR
1.62
46. Solid Biosciences SLDB
1.62
47. SCYNEXIS SCYX
1.61
48. Relmada Therapeutics RLMD
1.6
49. Universe Pharmaceuticals UPC
1.58
50. Supernus Pharmaceuticals SUPN
1.14
51. Harrow Health HROW
0.71
52. Collegium Pharmaceutical COLL
0.6
53. Zoetis ZTS
0.51
54. Amphastar Pharmaceuticals AMPH
0.33

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.